select a format

Single User License
USD 1500 INR 97185
Site License
USD 3000 INR 194370
Corporate User License
USD 4500 INR 291555

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Physica Pharma SAS-Product Pipeline Review-2015

Physica Pharma SAS-Product Pipeline Review-2015


  • Products Id :- GMDHC07454CDB
  • |
  • Pages: 22
  • |
  • August 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Physica Pharma SAS-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Physica Pharma SAS-Product Pipeline Review-2015', provides an overview of the Physica Pharma SAS's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Physica Pharma SAS's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Physica Pharma SAS including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Physica Pharma SAS's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Physica Pharma SAS's pipeline products

Reasons To Buy

Evaluate Physica Pharma SAS's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Physica Pharma SAS in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Physica Pharma SAS's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Physica Pharma SAS and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Physica Pharma SAS

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Physica Pharma SAS and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Physica Pharma SAS Snapshot 5

Physica Pharma SAS Overview 5

Key Information 5

Key Facts 5

Physica Pharma SAS-Research and Development Overview 6

Key Therapeutic Areas 6

Physica Pharma SAS-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Physica Pharma SAS-Pipeline Products Glance 10

Physica Pharma SAS-Early Stage Pipeline Products 10

Discovery Products/Combination Treatment Modalities 10

Physica Pharma SAS-Unknown Stage Pipeline Products 11

Unknown Products/Combination Treatment Modalities 11

Physica Pharma SAS-Drug Profiles 12

PHY-303 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

PHY-702 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

PHY-705 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

PHY-301 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

PHY-510 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Physica Pharma SAS-Pipeline Analysis 17

Physica Pharma SAS-Pipeline Products by Route of Administration 17

Physica Pharma SAS-Pipeline Products by Molecule Type 18

Physica Pharma SAS-Dormant Projects 19

Physica Pharma SAS-Locations And Subsidiaries 20

Head Office 20

Appendix 21

Methodology 21

Coverage 21

Secondary Research 21

Primary Research 21

Expert Panel Validation 21

Contact Us 21

Disclaimer 22

List of Tables

Physica Pharma SAS, Key Information 5

Physica Pharma SAS, Key Facts 5

Physica Pharma SAS-Pipeline by Indication, 2015 7

Physica Pharma SAS-Pipeline by Stage of Development, 2015 8

Physica Pharma SAS-Monotherapy Products in Pipeline, 2015 9

Physica Pharma SAS-Discovery, 2015 10

Physica Pharma SAS-Unknown, 2015 11

Physica Pharma SAS-Pipeline by Route of Administration, 2015 17

Physica Pharma SAS-Pipeline by Molecule Type, 2015 18

Physica Pharma SAS-Dormant Developmental Projects,2015 19

List of Figures

Physica Pharma SAS-Pipeline by Top 10 Indication, 2015 7

Physica Pharma SAS-Pipeline by Stage of Development, 2015 8

Physica Pharma SAS-Monotherapy Products in Pipeline, 2015 9

Physica Pharma SAS-Pipeline by Top 10 Route of Administration, 2015 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Physica Pharma SAS; Physica Pharma SAS - Key Therapeutics; Physica Pharma SAS - Pipeline Overview and Promising Molecules; Physica Pharma SAS - News; Physica Pharma SAS - Latest Updates; Physica Pharma SAS - Pipeline; Physica Pharma SAS - Discontinued/Dormant Projects


Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com